Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canadian Platform for Trials With Non-Invasive Brain Stimulation: Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke - A Feasibility Trial (Canstim: ConTRA-Stroke-F)

NCT04205526 is registered in ClinicalTrials.gov with Thiel, Alexander, M.D. as lead sponsor.

NCT NCT04205526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04205526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canadian Platform for Trials With Non-Invasive Brain Stimulation: Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke - A Feasibility Trial (Canstim: ConTRA-Stroke-F)
Lead sponsor
Thiel, Alexander, M.D.
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
December 31, 2025
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

feasibility study, post-stroke patients with cognitive deficits, post-stroke patients with upper extremity motor deficit